Clinical Trials on Pediatrisk Crohns sjukdom

Total 4779 results

AbbVie

Completed

An Observational Study to Assess Participant-Reported Real-World Experience of Risankizumab On-body Injector (OBI) for the Treatment of Crohn's Disease in Adult Participants in the United Kingdom (UK) (COMMODUS)

Crohn's Disease

United Kingdom
Janssen Research & Development, LLC

Active, not recruiting

A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease (GRAVITI)

Crohn Disease

Belgium, United States, Japan, Czechia, Hungary, Korea, Republic of, France, Taiwan, Germany, Malaysia, New Zealand, Poland, Canada, Turkey, Croatia, Israel, China, Denmark, Netherlands, Brazil, Italy, Spain, Jordan, Bosnia and Herzegovina and more
Janssen Research & Development, LLC

Active, not recruiting

A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease

Crohn Disease

China
Nantes University Hospital

Completed

Simplified Bowel Preparation Versus Standard Bowel Preparation Before Capsule Endoscopy in Patients With Crohn's Disease (CROHN-PREP)

Crohn Disease

France
Takeda

Active, not recruiting

A Study of CDPATH™ to Help Manage and Treat Crohn's Disease (COMPASS-CD)

Crohn's Disease

United States
Ventyx Biosciences, Inc

Active, not recruiting

VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease (Harmony-CD)

Crohn Disease

United States, Australia, Brazil, Bulgaria, Canada, Czechia, Georgia, Germany, Hungary, Israel, Italy, Lithuania, Moldova, Republic of, Poland, Slovakia
Sheba Medical Center

Active, not recruiting

Capsule & Omics for pRedicting Exacerbation of Crohn's Disease (CORE-CD)

Crohn's Disease

Israel
Erasmus Medical Center
Hospira, now a wholly owned subsidiary of Pfizer; ZonMw: The Netherlands Organisation...

Completed

Top-down Infliximab Study in Kids With Crohn's Disease (TISKids)

Crohn's Disease

Belgium, Netherlands, Finland
University of Miami
The Leona M. and Harry B. Helmsley Charitable Trust

Completed

Diet Intervention for Crohn's Disease Patient

Crohn Disease

United States
Prometheus Biosciences, Inc., a subsidiary of Merck...

Active, not recruiting

A Phase 2a Safety and Efficacy Open-Label Study of PRA023 in Subjects With Moderately to Severely Active Crohn's Disease (APOLLO-CD)

Crohn Disease

United States, Australia, Belgium, Canada, Czechia, France, Georgia, Poland
University of Pennsylvania
Crohn's and Colitis Foundation

Completed

Addressing Disability Effectively With Psychosocial Telemedicine (ADEPT)

Crohn Disease

United States
University of Pennsylvania
Children's Hospital of Philadelphia; Crohn's and Colitis Foundation

Completed

Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease (Holiday)

Crohn's Disease

United States
Pfizer

Completed

B0151005 Open-Label Extension Study (ANDANTE II)

Crohn's Disease

United States, Denmark, Israel, Ireland, Australia, Czechia, Canada, United Kingdom, Hungary, Germany, New Zealand, Brazil, Switzerland, Belgium, France, Italy
AbbVie

Completed

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy

Crohn's Disease
Celgene

Completed

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Crohn Disease

United States, Spain, Australia, Austria, Bulgaria, Canada, China, Colombia, Finland, France, Georgia, Germany, Greece, Hong Kong, Hungary, Israel, Korea, Republic of, Lithuania, Netherlands, Poland, Portugal, Russian Federation, Se... and more
NImmune Biopharma

Terminated

Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease

Crohn's Disease

United States
Sygehus Lillebaelt
Odense University Hospital; Hospital of South West Jutland

Completed

A Comparative Study of MRI, US and CE for Assessing Treatment Response in Known Crohn's Disease

Crohn Disease

Denmark
South Tyneside and Sunderland NHS Foundation Trust
Sheffield Teaching Hospitals NHS Foundation Trust; Newcastle University; County... and other collaborators

Terminated

PANenteric Crohn's Capsule Versus Ileo-Colonoscopy and Scan Study (PAN-ICS)

Crohn Disease

United Kingdom
Ferring Pharmaceuticals

Completed

Extension Study of Semapimod 60 mg IV x 3 Days (CD06)

Crohn's Disease

United States, Netherlands, Israel, Germany
Hoffmann-La Roche

Terminated

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 (JUNIPER)

Crohn Disease

United States, Israel, Spain, United Kingdom, Canada, Australia, Austria, Czechia, France, Italy, Netherlands, New Zealand, Russian Federation, Belgium, Brazil, Korea, Republic of, Germany, Bulgaria, Croatia, Hungary, Poland, Ukraine and more
Johnson & Johnson (China) Investment Ltd.

Completed

A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease

Crohn Disease

China
Janssen Research & Development, LLC

Active, not recruiting

A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection (PROGRESS)

Crohn's Disease

United States, Poland
Stanford University
G-Tech Corporation; The Leona M. and Harry B. Helmsley Charitable Trust

Completed

Myoelectric GutPrint-Crohn's Disease (Gutcheck-CD)

Crohn Disease

United States
AbbVie

Terminated

A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease (AIM-CD)

Crohn's Disease

United States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Slovakia, Spain, Taiwan, United...
UCB Biopharma SRL

Available

CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)

Crohn's Disease
Italfarmaco

Terminated

Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease (CD)

Crohn's Disease

Belgium, Italy, Netherlands
Geert D'Haens
Takeda

Completed

A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study (LOVE-CD)

Crohn Disease

Belgium, Netherlands, Hungary
NImmune Biopharma

Withdrawn

Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease

Crohn's Disease
Hospital Mutua de Terrassa

Completed

Histopathologic and Lymphocyte Subpopulations Evaluation of the Upper Gastrointestinal Tract of Crohn's Disease (CROHNLY)

Crohn Disease

Spain
Janssen Korea, Ltd., Korea

Completed

Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab) (STELARA CD PMS)

Crohn Disease

Korea, Republic of
Reistone Biopharma Company Limited

Completed

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

Crohn's Disease

China, Poland, Ukraine, United States
4YouandMe
Icahn School of Medicine at Mount Sinai; Oxford University Hospitals NHS Trust and other collaborators

Completed

Stress in Crohn's Disease

Crohn Disease

United States, United Kingdom
AbbVie

Completed

A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies (U-EXCEL)

Crohn's Disease

United States, Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Egypt, Estonia, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy and more
Melbourne Health
Medtronic

Completed

Capsule Colonoscopy in Crohn's Disease and Its Correlation With Conventional Colonoscopy and Faecal Calprotectin

Crohn's Disease

Australia
Hospices Civils de Lyon

Withdrawn

Identification by Cytometry by Mass of Predictive Immunological Profiles of Answer to Treatmentby Biotherapics for Patients With Crohn's Disease (PICTURE)

Crohn Disease
Eli Lilly and Company

Completed

A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease (SERENITY)

Crohn's Disease

United States, Belgium, Netherlands, Australia, Hungary, United Kingdom, Czechia, Poland, Switzerland, Japan, Romania, Ukraine, Russian Federation, Canada
Ionis Pharmaceuticals, Inc.

Completed

Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease

Crohn's Disease

Poland, Spain, Belgium, Germany, Czechia, Italy
Lument AB
LINK Medical Research

Completed

Trial Evaluating the Diagnostic Usefulness of Lumentin® 44 When Used as Contrast Agent

Crohn Disease

Sweden
AbbVie

Completed

A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Crohn's Disease

United States, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Estonia, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Japan, Korea, Republic... and more
AbbVie

Completed

A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment

Crohn's Disease

United States, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Egypt, Estonia, France, Germany, Greece, Ireland, Israel, Italy, Korea, Republic... and more
MediBeacon

Completed

Oral Administration of MB-102 Versus Dual Sugar Testing for Gut Permeability

Crohn Disease

United States
Prof. Arie Levine

Completed

The Crohn's Disease Exclusion Diet With Partial Enteral Nutrition or Alone in Adult Patients With Crohn's Disease (CDED-AD)

Crohn's Disease

Israel
Prof. Arie Levine

Completed

Diet for Induction and Maintenance of Remission and Re-biosis in Crohn's Disease (DIETOMICS-CD)

Crohn's Disease

Israel, Canada, Ireland, Spain
Takeda

Completed

Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)

Crohn's Disease

Belgium, Israel, Korea, Republic of, Netherlands, Australia, Denmark, Russian Federation, Hungary, Serbia, Bulgaria, Canada, Germany, Italy, Poland, Slovakia, Czechia, Mexico, Romania, Brazil, Estonia, United States, Bosnia and Herzegovina and more
Shire

Terminated

Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307) (CARMEN CD 307)

Crohn's Disease

Spain, United States, Korea, Republic of, Australia, Romania, Hungary, Israel, Italy, Croatia, Belgium, Bulgaria, Germany, Poland, Portugal, Argentina, United Kingdom, Greece, New Zealand, Austria, Bosnia and Herzegovina, Colombia, Eston... and more
Copenhagen University Hospital at Herlev

Completed

Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission (STOP IT)

Crohn Disease

Sweden, Denmark, Finland, Norway
Children's Hospital of Philadelphia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...

Completed

Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease (Holiday)

Crohn Disease

United States
Mesoblast, Inc.

Completed

Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease

Crohn's Disease

United States, Canada
Mayo Clinic

Terminated

Ultrasound Evaluation of Crohn's Disease

Crohn Disease

United States
Shire

Completed

Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease (OPERA)

Crohn's Disease

Korea, Republic of, United States, Spain, Japan, Serbia, Germany, Belgium, Netherlands, Poland, Austria, Bulgaria, Canada, France, Norway, Slovakia, South Africa

Clinical Trials on Pediatrisk Crohns sjukdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations